Viewing Study NCT07021950


Ignite Creation Date: 2025-12-24 @ 4:58 PM
Ignite Modification Date: 2026-02-22 @ 4:13 AM
Study NCT ID: NCT07021950
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-15
First Post: 2025-06-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module